Sign in
CompletedNo phase

Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder

Key facts

Who runs it
West Virginia University
Where
Morgantown, United StatesSee the site
Trial code
Status
Completed
People taking part
1 person enrolled
Started
1 Jul 2023
Ended
28 Jun 2024
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • Deep Brain Stimulation
Record updated
6 March 2026

Who can take part

Age
22 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Age 22-50 years at time of enrollment
  • Fulfills current DSM-5 diagnostic criteria for severe OUD with at least a 5-year history
  • Participants may have comorbid SUD diagnoses at a mild, moderate or severe level, however, OUD must be the primary disorder for which the individual is seeking treatment and the other use disorders must occur in the context of relapse
  • At least one lifetime overdose survival
  • Demonstrated greater than five years of refractory symptoms of OUD

Who cannot take part

  • Diagnosis of acute myocardial infarction or cardiac arrest 1 within the previous 6 months
  • Past or present diagnosis of schizophrenia, psychotic disorder, bipolar disorder, or untreated depression other than one determined to be substance induced
  • Unable to undergo MR-imaging

Where in United States

  • West Virginia University Rockefeller Neuroscience InstituteMorgantown, United States

About the trial

What the trial wants to find out

The purpose of this clinical study is to investigate the safety, tolerability, and feasibility of Deep Brain Stimulation (DBS) of the nucleus accumbens (NAc) and ventral internal capsule (VC) for participants with treatment refractory opioid use disorder (OUD) who have cognitive, behavioral, and functional disability.

The 2 groups in the trial

  • DBS-ON OnlyTreatment being tested

    Titration will be based on stimulation parameters used in previous studies examining the role of DBS of the NAc in the treatment of OCD and depression as well as the parameters utilized in the initial pilot study conducted by the team. Participants receive active stimulation after surgery and throughout the remaineder of the study.

    Treatment: Deep Brain Stimulation

  • DBS-OFF, then DBS-ONSham treatment, for comparison

    Titration sessions will be conducted identically to the "DBS-ON" arm, the only difference is that no stimulation is delivered for the first 12 weeks and therefore, no actual adjustments made. At Study Week 12, stimulation is turn on and continues for the remainder of the study.

    Treatment: Deep Brain Stimulation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized, Sham-Controlled Trial Investigating Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder
Record updated
6 March 2026